Roger Schechter, MD
Emergency Medicine · Escondido, CANPI 1346257649
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 61.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $12,314 and has fallen 95.5% since, to $558 in 2025. Among emergency medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $160.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$11K
- Merz North America, Inc.$6K
- Smith+Nephew$169
- Integra Lifesciences Corporation$150
- Mylan Specialty L.p.$125
- Musculoskeletal Transplant Foundation Inc.$61
- plus $113 from 3 others
What the payments were for
- Speaking & faculty fees$9,98655%
- Travel & lodging$8455%
- Food & beverage$7,48641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 26 | $11,227 |
| Merz North America, Inc. | 77 | $6,473 |
| Smith+Nephew | 3 | $169 |
| Integra Lifesciences Corporation | 2 | $150 |
| Mylan Specialty L.p. | 1 | $125 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $61 |
| Kerecis Limited | 1 | $52 |
| AbbVie | 2 | $46 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$9,676
- Dermagraft$9,676
- Puraply/Affinity/NuTech$9,676
- XEOMIN$1,579
- ASCLERA$1,110
- PuraPly$917
- Yupelri$125
- Puraply Antimicrobial$123
- Stravix$122
- Grafix$122
- STRAVIX PL$122
- GRAFIX PL$122
- OMNIGRAFT$108
- PRIMATRIX$108
- MEDIHONEY$108
- TCC-EZ$108
- AMNIOEXCEL$108
How this compares
$18,317 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 15 | $319 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Escondido
- Amanda HoldenEscondido$103K
- Michael BlueLone Pine$915K
- Andrew AccardiEncinitas$383K
- Fredrick Melik-AbrahamianSylmar$354K
- Graham WalkerStanford$309K
- Douglas WhiteOakland$220K
- Paul PearigenSan Diego$208K
- Richard KozakMission Viejo$203K
- Oron FrenkelSan Francisco$201K
- Matthew KaplanMission Viejo$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.